# Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers

> **NCT03044327** · NA · COMPLETED · sponsor: **Fraunhofer-Institute of Toxicology and Experimental Medicine** · enrollment: 11 (actual)

## Conditions studied

- Healthy

## Interventions

- **PROCEDURE:** LPS challenge

## Key facts

- **NCT ID:** NCT03044327
- **Lead sponsor:** Fraunhofer-Institute of Toxicology and Experimental Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03044327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03044327, "Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03044327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*